EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antigenic Dark Matter: Unexplored Post-Translational Modifications of Tumor-Associated and Tumor-Specific Antigens in Pancreatic Cancer

Amin Safa, Idris Vruzhaj iD, Marta Gambirasi iD, Giuseppe Toffoli iD

Cancers · 30.10.2025 · 17 (21) · 3506

DOI: 10.3390/cancers17213506 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 30.10.2025. Verfasst von Amin Safa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Research and Development, Duy Tan University, Da Nang 550000, Vietnam. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 262 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health (Ricerca Corrente).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreatic ductal adenocarcinoma (PDAC) exhibits marked resistance to immunotherapy. Beyond its characteristically low tumor mutational burden, post-translational modifications (PTMs) remodel the immunopeptidome and promote immune escape through reversible, enzyme-driven programs. Subject Matter: We synthesize evidence that aberrant glycosylation, O-GlcNAcylation, phosphorylation, and citrullination constitute core determinants of antigen visibility operating within spatially discrete tumor niches and a desmoplastic stroma. In hypoxic regions, HIF-linked hexosamine metabolism and OGT activity stabilize immune checkpoints and attenuate antigen processing; at tumor margins, sialylated mucins engage inhibitory Siglec receptors on innate and adaptive lymphocytes; within the stroma, PAD4-dependent NET formation enforces T cell exclusion. We also delineate technical barriers to discovering PTM antigens labile chemistry, low stoichiometry, and method-embedded biases and outline practical solutions: ETD/EThcD/AI-ETD fragmentation, PTM-aware database searching and machine-learning models, and autologous validation in patient-derived organoid–T cell co-cultures. Finally, we highlight therapeutic strategies that either immunize against PTM neoepitopes or inhibit PTM machinery (e.g., PAD4, OGT, ST6GAL1), with stromal remodeling as an enabling adjunct.

Conclusions

PTM biology, spatial omics, and patient sample models can uncover targetable niches and speed up PDAC vaccination, TCR, and enzyme-directed treatment development.

Schlagwörter

Stichwörter der Autor:innen

citrullinationglycosylationimmune Evasionimmunopeptidomicspancreatic ductal adenocarcinomapost-translational modifications

Autor:innen und Institutionen

  • Institute of Research and Development, Duy Tan University, Da Nang 550000, Vietnam.
  • School of Medicine and Pharmacy, Duy Tan University, Da Nang 550000, Vietnam.
  • Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
  • Ludwig Institute for Cancer Research, Department of Oncology, University of Lausanne and Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland.
  • Department of Pharmaceutical and Pharmacological Sciences, University of Padua, 35131 Padua, Italy.
  • Department of Immunology, School of Medicine, Zabol University of Medical Sciences, Zabol 98616-15881, Iran.

ORCID-Profile: Idris Vruzhaj, Marta Gambirasi, Giuseppe Toffoli

Förderung

  • Italian Ministry of Health (Ricerca Corrente)

Zitieren

APA

Safa, A., Vruzhaj, I., Gambirasi, M., & Toffoli, G. (2025). Antigenic Dark Matter: Unexplored Post-Translational Modifications of Tumor-Associated and Tumor-Specific Antigens in Pancreatic Cancer. Cancers, 17(21), 3506. https://doi.org/10.3390/cancers17213506

Vancouver

Safa A, Vruzhaj I, Gambirasi M, Toffoli G. Antigenic Dark Matter: Unexplored Post-Translational Modifications of Tumor-Associated and Tumor-Specific Antigens in Pancreatic Cancer. Cancers. 2025;17(21):3506. doi:10.3390/cancers17213506

BibTeX
@article{Safa2025,
  author = {Safa, Amin and Vruzhaj, Idris and Gambirasi, Marta and Toffoli, Giuseppe},
  title = {Antigenic Dark Matter: Unexplored Post-Translational Modifications of Tumor-Associated and Tumor-Specific Antigens in Pancreatic Cancer},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {21},
  pages = {3506},
  doi = {10.3390/cancers17213506}
}
Kostenlos starten →